Amgen Director Michael V. Drake Receives 665 Restricted Stock Units

This Form 4 filing reports that Amgen Inc. director Michael V. Drake received 665 restricted stock units (RSUs) on May 19, 2026, with a total post-transaction holding of 5,774.2869 shares. The RSUs were granted under Amgen's 2009 Director Incentive Program and vested immediately, with the shares being paid out on a one-to-one basis. The filing includes footnotes explaining that vested RSUs may be deferred by the director, and that the holdings include 339 dividend equivalents (DEs) granted under the company's equity incentive plan. The DEs are credited to unvested RSUs and paid out in shares according to the vesting schedule. The transaction was reported as an acquisition (code A) with a price per share of $0, which is typical for equity awards. The filing was signed by Michael V. Drake on May 20, 2026, and reflects standard director compensation practices.